Submitted by Anonymous (not verified) on 12 December 2025 - 14:20
Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Date of authorisation: 28/11/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Date of authorisation: 28/11/2025, Status: Authorised